Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease

被引:0
|
作者
Tama Dinur
Majdolen Istaiti
Dafna Frydman
Michal Becker-Cohen
Jeff Szer
Ari Zimran
Shoshana Revel-Vilk
机构
[1] Shaare Zedek Medical Centre,Gaucher Unit
[2] The Hebrew University of Jerusalem,Faculty of Medicine
[3] Royal Melbourne Hospital,Peter MacCallum Cancer Centre
[4] University of Melbourne,Department of Medicine
关键词
Gaucher disease; Patients reported outcome; Mobile survey; Adult patients; Quality of life;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease
    Dinur, Tama
    Istaiti, Majdolen
    Frydman, Dafna
    Becker-Cohen, Michal
    Szer, Jeff
    Zimran, Ari
    Revel-Vilk, Shoshana
    ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
  • [2] Gaucher disease specific patients reported outcome measures: A mobile phone survey
    Dinur, Tama
    Istaiti, Majdolen
    Frydman, Dafna
    Beckher-Cohen, Michal
    Zimran, Ari
    Revel-Vilk, Shoshana
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S49 - S49
  • [3] Bone density and treatment response in a large cohort of patients with type 1 Gaucher disease
    Anstett, Kara
    Lau, Heather A.
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S23 - S23
  • [4] Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials
    Elstein, Deborahy
    Belmatoug, Nadia
    Deegan, Patrick
    Goker-Alpan, Ozlem
    Hughes, Derralynn A.
    Schwartz, Ida Vanessa D.
    Weinreb, Neal
    Bonner, Nicola
    Panter, Charlotte
    Fountain, Donna
    Lenny, Andrew
    Longworth, Louise
    Miller, Rachael
    Shah, Koonal
    Schenk, Jorn
    Sen, Rohini
    Zimran, Ari
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [5] Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials
    Deborah Elstein
    Nadia Belmatoug
    Patrick Deegan
    Özlem Göker-Alpan
    Derralynn A. Hughes
    Ida Vanessa D. Schwartz
    Neal Weinreb
    Nicola Bonner
    Charlotte Panter
    Donna Fountain
    Andrew Lenny
    Louise Longworth
    Rachael Miller
    Koonal Shah
    Jörn Schenk
    Rohini Sen
    Ari Zimran
    Orphanet Journal of Rare Diseases, 17
  • [6] Family reported outcome measures and patient reported outcome measures in Multiple Myeloma patients
    Midlig, Kareem
    Draliuk, Regina
    Silverman, Barbara
    Preis, Meir
    Ballan-Haj, Mouna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S107 - S108
  • [7] Family Reported Outcome Measures and Patient Reported Outcome Measures in Multiple Myeloma Patients
    Midlig, Kareem
    Draliuk, Regina
    Preis, Meir
    Silverman, Barbara
    Ballan, Mouna
    BLOOD, 2021, 138
  • [8] REVIEW OF PATIENT-REPORTED OUTCOME MEASURES FOR USE IN MYOTONIC DYSTROPHY TYPE 1 PATIENTS
    Symonds, Tara
    Randall, Jason A.
    Campbell, Patrick
    MUSCLE & NERVE, 2017, 56 (01) : 86 - 92
  • [9] Gaucher disease (GD)-specific patient-reported outcome (PRO) measures for clinical monitoring and for clinical trials
    Elstein, Deborah
    Klemen, Martin
    Panter, Charlotte
    Bonner, Nicola
    Johnson, Chloe
    Zimran, Ari
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S52 - S52
  • [10] Identification of patient-reported outcomes measures (PROMs) and patient-reported experiences measures (PREMs) in Gaucher disease in Spain
    Giraldo, Pilar
    Camprodon, Maria
    Alcolea, Paloma Cerro
    Gras-Colomer, Elena
    Ibarretxe, Daiana
    Lakhwani, Sunil
    Mora, Elvira
    Calderon, Maria Purificacion Velasco
    Morales-Conejo, Montserrat
    MEDICINA CLINICA, 2024, 163 (09): : 449 - 457